Lupin is presently buying and selling at Rs. 806.10, up via 2.15 points or 0.27% from its previous closing of Rs. 803.95 on the BSE.

The scrip opened at Rs. 805.05 and has touched a excessive and low of Rs. 812.00 and Rs. 803.25 respectively. So some distance 24871 stocks had been traded at the counter.

The BSE institution ‘A’ stock of face fee Rs. 2 has touched a 52 week excessive of Rs. 986.00 on 10-Sep-2018 and a 52 week low of Rs. 720.Forty on 28-Mar-2019.

Last one week excessive and coffee of the scrip stood at Rs. 817.25 and Rs. 782.10 respectively. The present day market cap of the corporation is Rs. 36527.55 crore

The promoters conserving within the business enterprise stood at forty six.98%, at the same time as Institutions and Non-Institutions held 38.84% and 14.18% respectively.

Lupin has released Fluoxetine Tablets USP, 60mg, having received an approval from america Food and Drug Administration (FDA) earlier. Fluoxetine Tablets USP, 60mg, is the prevalent model of Alvogen Group Holdings three LLC’s Fluoxetine Tablets, 60mg.

It is indicated within the remedy of Major Depressive Disorder (MDD), Obsessive Compulsive Disorder (OCD), Bulimia Nervosa and panic ailment, without or with agoraphobia. Fluoxetine Tablets, 60mg, had annual income of approximately $41 million inside the US (IQVIA MAT February 2019).